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68 The Journal of Thoracic and Cardioackground: Residual or recurrent mitral regurgitation frequently occurs after mitral
alve repair for ischemic mitral regurgitation with an annuloplasty ring. Because
nnuloplasty primarily addresses annular dilatation, we studied an adjunctive tech-
ique that might correct restricted leaflet (Carpentier type IIIb) systolic closing
otion, which often accompanies annular dilatation in patients with ischemic mitral
egurgitation.
ethods: Six sheep had radiopaque markers placed on the left ventricle, mitral
eaflets and annulus, and mitral subvalvular apparatus. A pericardial patch was
utured into the middle scallop of the posterior mitral valve leaflet and furled in with
reefing stitch placed in the radial axis. Posterolateral left ventricular myocardial
schemia was created by using proximal circumflex occlusion to induce acute
schemic mitral regurgitation. Under open-chest conditions, 3-dimensional marker
oordinates were measured by using biplane videofluoroscopy at baseline and
uring acute ischemia both before and after release of the reefing stitch (leaflet
xtension); transesophageal echocardiography was used to grade ischemic mitral
egurgitation.
esults: Leaflet apical systolic tethering was not improved by leaflet extension, but
schemic mitral regurgitation decreased (control, 0.9  0.3*; ischemia, 2.4  0.3;
eaflet extension, 1.5  0.3; *P  0.002). Posterior mitral valve leaflet midline
ength (control, 1.45  0.09*; ischemia, 1.53  0.10; leaflet extension, 1.83 
.13*; *P  0.001) and posterior mitral valve leaflet middle scallop area (control,
.66  0.20 cm2*; ischemia, 1.91  0.22 cm2; leaflet extension, 2.36  0.22 cm2*;
P  0.006) increased with leaflet extension because of patch unfurling (mean  1
tandard error of the mean; repeated-measures analysis of variance, Dunnet post-hoc
est vs ischemia).
onclusions: Posterior mitral valve leaflet extension ameliorated acute ischemic
itral regurgitation but did not correct the abnormal apically restricted systolic
osterior mitral valve leaflet closing motion. This technique might be a useful
djunct repair in combination with ring annuloplasty for ischemic mitral regurgita-
ion, but the clinical role of this adjunct remains to be defined in patients.
schemic mitral regurgitation (IMR) is a frequent complication of myocardial
infarction and is associated with a poor prognosis.1,2 Residual or recurren
mitral regurgitation (MR) is seen in upward of 30% of patients3-6 after ring
nnuloplasty (RA), the most common repair technique used for IMR. Although a
ew groups have recently reported encouraging midterm results after undersized
A,7-9 IMR remains a vexing problem in most other centers. Undersized an
eduction has been shown to correct both annular and subvalvular geometry in
MR,10 but annular reduction with RA primarily addresses the annular dilatatio
omponent. The systolic leaflet tethering (LT) component of IMR (or Carpentier type
vascular Surgery ● April 2006
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A
CDIIb restricted leaflet closing motion) caused by posterior pap-
llary muscle displacement often persists and might even
orsen with continued left ventricular (LV) remodeling, which
an result in repair failure.4,5 Several investigators have pro-
osed alternative repair techniques, but none of these 
iques has received widespread clinical acceptance.
Although leaflet extension (LEX) has been used 
atients with restricted leaflet motion resulting from rh
atic valve disease,11 it has only occasionally been used
atients with IMR. Dobre and coworkers12 reported 2 pa-
ients in whom extension of the posterior mitral leaflet
PML) with a pericardial patch was performed as an adjunct
o RA. Based on this notion and the observation that per-
istent MR after RA is associated with increased LT of the
ML,13 we tested the hypothesis that patch extension of
ML ameliorates LT and thereby reduces IMR in an ovine
odel of acute IMR without concomitant annular reduction.
ethods
urgical Preparation
ix sheep (66  4 kg) were premedicated with ketamine
25 mg/kg administered intramuscularly) and anesthetized with
odium thiopental (6.8 mg/kg administered intravenously) and
aintained with inhalational isoflurane (1%-2.5%). Through a left
horacotomy, miniature tantalum myocardial markers (nos. 2-14;
igure 1, A) were inserted in the LV subepicardium alon
qually spaced longitudinal meridians, with one marker at the LV
pex (no. 1; Fig 1, A). A snare was placed around the left circ
ex coronary artery proximal to the first obtuse marginal branch.
On cardiopulmonary bypass (120  6 minutes), the ascending
orta was crossclamped (89  5 min), and the heart was arrested
ith retrograde crystalloid cardioplegia. Through a left atriotomy,
iniature tantalum markers were placed at the tips and bases of
oth anterior and posterior papillary muscles (anterior papillary
uscles nos. 28 and 29 and posterior papillary muscles 30 and 31).
ight markers were sutured around the circumference of the mitral
nnulus (one near each commissure [nos. 16 and 20] and 3 along
he septal [nos. 15, 21, and 22] and lateral [nos. 17, 18, and 19]
nnulus; Figure 1, A and B). Leaflet edge markers were sutured 
he ventricular side of the anterior mitral leaflet (AML) and PML
Abbreviations and Acronyms
AML  anterior mitral leaflet
ANOVA analysis of variance
3-D  3-dimensional
IMR  ischemic mitral regurgitation
LEX  leaflet extension
LT  leaflet tethering
LV  left ventricular
MR mitral regurgitation
PML  posterior mitral leaflet
PPM  posterior papillary muscle
RA  ring annuloplastydges at the leaflet center (nos. 25 and 26; Figure 1, B). Markers n
The Journal of Thoracicere also sutured to the atrial side of the AML along the midline
nos. 23 and 24; Figure 1, B).
The middle scallop of the PML was detached from the annulus for
distance of approximately 15 mm, preserving the attachments of the
econd-order chordae on the leaflet side of the incision. A pericardial
atch was sized and sutured into this defect with a running 7-0
olypropylene suture. A gold marker (no. 27; Figure 1, B) was
ncorporated in the suture line in the PML midline to define the
atch-leaflet junction. After completion of the suture lines, the
atch was furled toward the annulus (Figure 1, C) by using a 5
olypropylene reefing stitch, which was exteriorized through the
eft atrial wall, and a tourniquet.
The atriotomy was closed, the heart was deaired, the cross-
lamp was removed, and the heart was defibrillated (dopamine,
.2  1.0 g · kg1 · min1). A pressure transducer (Millar
PC-500; Millar Instruments, Inc, Houston, Tex) was placed in the
V chamber through the apex.
xperimental Protocol
he animals were transferred to the catheterization laboratory 
tudied intubated with the chest open. Anesthesia was maintained
ith inhalational isoflurane (1%-2.5%). Animals received 100 mg
f lidocaine (administered intravenously) as prophylaxis against
rrhythmias. Simultaneous biplane videofluoroscopic marker im-
ges and hemodynamic data were acquired at baseline (preisch-
mia), during proximal circumflex ischemia (ischemia), and during
ngoing ischemia after release of the patch reefing suture (patch
xtension; Figure 1, D). The severity of IMR was graded by
xperienced cardiologist (D.L.) according to the extent and width
f the color Doppler regurgitant jet visualized with transesopha-
eal echocardiography and categorized as none (0), trace (0.5),
ild (1), moderate (2), moderate-severe (3), or severe
4).14 The data acquisition sequences labeled “ischemia” w
tarted as soon as moderate IMR was observed (45-90 seconds
fter occlusion).
All animals received humane care in compliance with the
Principles of Laboratory Animal Care” formulated by the Na-
ional Society for Medical Research and the “Guide for Care and
se of Laboratory Animals” prepared by the National Academy of
ciences and published by the National Institutes of Health
DHEW NIHG publication no. 85-23, revised 1985). This study
as approved by the Stanford University Medical School Labora-
ory Research Animal Review committee and conducted according
o Stanford University policy.
ata Acquisition
Philips Optimus 2000 biplane Lateral ARC 2/poly DIAGNOST
2 system (Philips Medical Systems, Pleasanton, Calif) was used
o record biplane videofluoroscopic images at 60 Hz with the
nimal in the right lateral decubitus position and ventilation ar-
ested at end expiration. Two-dimensional images from each of the
radiographic views (right anterior oblique and left anterior
blique) were digitized by using custom software and merged to
ield 3-dimensional (3-D) coordinates for each radiopaque marker
very 16.7 ms, with an accuracy of 0.1  0.3 mm compared with
nown marker-to-marker 3-D lengths.15 Analog LV pressure an
lectrocardiographic voltage were digitized and recorded simulta-
eously with the marker images.
and Cardiovascular Surgery ● Volume 131, Number 4 869
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A
CData Analysis
Cardiac cycle timing and hemodynamics. For each cardiac
ycle, end systole was defined as the videofluroscopic frame im-
ediately before the peak rate of change of falling LV pressure
dP/dt) and end diastole as the frame containing the maximum
ositive second time derivative of LV pressure corresponding with
he frame immediately before the upstroke of the LV pressure
urve. Instantaneous LV volume was calculated for each frame
rom the epicardial LV and mitral annular markers by using a
pace-filling multiple tetrahedral model constructed from the
arker coordinates and corrected for LV convexity.16
Mitral annular geometry. Mitral annular area was calculated
s the sum of the areas of 8 triangles formed by consecutive
djacent marker pairs on the annulus (nos. 15-22; Figure 1, B) and
he annular centroid, without assumption of planar geometry.
Figure 1. A, Schematic representation of the radiopaq
leaflet; PML, posterior mitral leaflet; ACOM, anterior
papillary muscle; PPM, posterior papillary muscle. B, S
array. The pericardial patch was placed close to the a
ACOM, Anterior commissure; PCOM, posterior commiss
and posterior mitral leaflet with sutured markers in s
detached from the annulus, and a patch of autologous p
The patch was initially retracted with a reefing stitch
Posterior mitral leaflet.nnular septal-lateral diameter was calculated as the distance in f
70 The Journal of Thoracic and Cardiovascular Surgery ● Apri-D space between the 2 markers placed in the middle of the septal
nd lateral mitral annulus (nos. 22 and 18; Figure 1, B).
PML geometry. To characterize precisely the end-systolic po-
ition of the PML with respect to the mitral annulus, 3-D marker
oordinates were transformed from their original laboratory refer-
nce system to a right-handed Cartesian coordinate system with
he origin at the midseptal annulus (saddle horn, marker no. 22;
igure 1, A and B), the positive lateral axis directed toward 
idlateral annulus (marker no. 18), the positive apical axis passing
hrough the LV apex (marker no. 1), and the positive posterior axis
irected toward the posterior commissure.
The length of the pericardial patch was defined as the distance
etween the midlateral annulus marker (no. 18; Figure 1, B) and
he patch edge marker (no. 27). Leaflet midline length was calcu-
ated as the sum of patch width and the distance between the PML
arker array used in this study. AML, Anterior mitral
issure; PCOM, posterior commissure; APM, anterior
atic representation of the annular and leaflet markers
s in the middle scallop of the posterior mitral leaflet.
, This photograph depicts the posterior mitral annulus
he middle scallop of the posterior mitral leaflet was
rdium was sewn into this defect to extend the leaflet.
Patch unfurled by release of the reefing stitch. PML,ue m
comm
chem
nnulu
ure. C
itu. T
erica
. D,ree edge marker (no. 26; Figure 1, B) and the patch edge marker
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A
CDno. 27). PML middle scallop area was calculated as the sum of the
reas of 4 triangles formed by consecutive adjacent marker pairs
nd the centroid (nos. 26, 17, 18, and 19; Figure 1, B).
tatistical Analysis
ll data are reported as means  1 standard error of the mean.
emodynamic and marker-derived data from 2 consecutive
teady-state beats were time aligned at end systole, and data from
hese beats were averaged for each animal and data acquisition run.
omparisons between the different conditions were made by using
epeated-measures analysis of variance (ANOVA) after normal
istribution had been established with the Kolmogorov-Smirnov
est. If non-Gaussian data distribution was encountered, Friedman
epeated-measures ANOVA on ranks was applied. If ANOVA
ielded a significant F value (P  .05), the Dunnett test was applied
or post-hoc testing, with ischemia as the control condition.
esults
able 1 summarizes group mean hemodynamic data for
reischemia, ischemia, and LEX conditions. During isch-
mia, IMR occurred, LV end-diastolic pressure increased
ignificantly, and LV dP/dt and LV end-systolic pressure
ecreased. During LEX, neither heart rate, LV volumes, nor
ressures changed, despite ongoing ischemia. MR, how-
ver, was less after LEX (control, 0.9  0.3*; ischemia,
.4  0.3; LEX, 1.5  0.3*; *P  .002) compared with
schemia.
Ischemia resulted in mitral annular dilatation, as re-
ected by increased end-systolic mitral annular area and
nd-systolic septal-lateral annular diameter (Table 2). LE
ncreased end-systolic patch length, PML midline length,
nd PML middle scallop area (Table 3).
ABLE 1. Hemodynamic data
Preischemia
R (min1) 128 5
P/dtmax (mm Hg · s
1) 2784 467*
VESV (mL) 172 16
VEDV (mL) 224 18
VESP (mm Hg) 88 9*
VEDP (mm Hg) 11 6*
R 0.9 0.3*
alues are presented as means  standard error of the mean. LEX, Leafle
nd-systolic volume; LVEDV, left ventricular end-diastolic volume; LVESP
ressure; MR, mitral regurgitation. *P  .05 versus ischemia, repeated-m
ABLE 2. Mitral annular parameters
Preischemia 
nd-systolic septal-lateral diameter (cm) 2.55 0.15*
nd-systolic mitral-annular area (cm2) 7.47 1.00*
alues are presented as means  standard error of the mean. LEX
epeated-measures analysis of variance with the Dunnet post-hoc test.
The Journal of ThoracicFigures 2 and 3 show t h e c anges in PML geometry. Durin
schemia, the lateral annulus moved laterally (Figure 2), 
he PML edge was tethered apically by 0.09  0.03 cm,
hich is indicative of Carpentier Type IIIb restricted sys-
olic leaflet closing motion (Figures 2 and 3). With LEX
atch edge moved toward the septum as patch length in-
reased (Figure 2), and the leaflet edge marker m
urther apically (0.14  0.03* cm, P  .001) as leaflet
ength increased (Figure 3). Even though LEX exacerb
T, IMR was reduced, probably because of increased leaflet
oaptation height and area.
iscussion
hese findings show that patch extension of the PML reduces
he degree of IMR, even in the absence of concomitant annular
eduction, in an ovine model of acute IMR. Rather than
meliorating LT as hypothesized, however, LEX worsened
ystolic PML apical restriction. Although LEX might im-
rove leaflet coaptation by augmenting leaflet area, espe-
ially if combined with RA, the clinical utility of this
echnically complex adjunct remains to be defined.
Aggressive treatment of IMR is based on the fact that
MR is not a benign condition: it carries a 2-fold excess
ortality of 62% at 5 years in postinfarction patients, irre-
pective of other risk factors.2 In addition, IMR is probab
progressive disorder in which MR-related LV volume
verload promotes or exacerbates further LV postinfarction
emodeling, which leads to worsening MR. Mitral valve
epair, rather than replacement, is the procedure of choice
or patients with most forms of MR, and RA has evolved to
Ischemia LEX ANOVA
128 5 129 4 P  NS
1936 242 1600 214 P  .001
178 15 183 16 P  .03
225 17 229 17 P  .03
69 4 66  5 P  .001
21 2 22  2 P  .006
2.4 0.3 1.5 0.3* P  .002
nsion; ANOVA, analysis of variance; HR, heart rate; LVESV, left ventricular
ventricular end-systolic pressure; LVEDP, left ventricular end-diastolic
res analysis of variance with the Dunnet post– hoc test.
Ischemia LEX ANOVA
2.94 0.15 3.07  0.18* P  .001
8.91 0.97 9.48  1.03* P  .001
flet extension; ANOVA, analysis of variance. *P  .05 vs ischemia,t exte
, left, Leaand Cardiovascular Surgery ● Volume 131, Number 4 871
b
r
l
r
n
t s
p e
u
a
b
a
s
a
i en
o
e
t
l t
s
c
I
e
t
r
T
E
E
E
V
. nnet p
F
m
T
t
m
t
F
l
l
i
F
m
e
s
m
i
Surgery for Acquired Cardiovascular Disease Langer et al
8
A
CDecome the key procedure for patients with IMR, aiming to
educe the size of the dilated mitral annulus to improve
eaflet coaptation. Although RA improves coaptation by
estoring septal-lateral annular diameter, it frequently does
ot sufficiently correct LT in patients with severe Carpentier
ype IIIb restricted systolic leaflet motion.4 To address thi
roblem, Bolling and colleagues17 first demonstrated th
tility of undersized RA for patients with functional MR as
n annular solution to a ventricular problem, addressing
oth the MR and the ventricular dilation. Recently, favor-
ble results have been reported in patients with IMR after
uch restrictive RA, with minimal recurrent or residual MR
t midterm follow-up and with reverse remodeling observed
n some patients.7-9 Nevertheless, recurrent IMR has be
bserved in upward of 30% of patients after RA in experi-
nced centers, irrespective of ring type or size.3-6 Even
hough undersized annular reduction can correct both annu-
ar and subvalvular geometry in IMR,10 such might no
ABLE 3. Posterior mitral valve leaflet parameter associat
Preischemia
nd-systolic patch length (cm) 0.57 0.05
nd-systolic PML midline length (cm) 1.45 0.09
nd-systolic middle scallop area (cm2) 1.66  0.20*
alues are presented as means  standard error of the mean. LEX, Leafl
05 versus ischemia, repeated-measures analysis of variance with the Du
igure 2. The coordinates of the posterior leaflet central meridian
arkers were projected onto a 2-dimensional plot at end systole.
he mitral septal-lateral axis is on the abscissa, with the ven-
ricular apical-basal axis on the ordinate. The lateral annular
arker is seen on the upper right, with the leaflet edge marker in
he lower left (numbers correspond with labeled markers, see
igure 1, B). During ischemia, the lateral annular marker moves
aterally (consistent with annular septal-lateral dilation), and the
eaflet edge marker is apically displaced. Leaflet extension (LEX)
ncreases effective leaflet length. PML, Posterior mitral leaflet. l
72 The Journal of Thoracic and Cardiovascular Surgery ● Apriufficiently correct the subvalvular problem in patients with
ontinued LV dilation and remodeling.4,5
Based on the mechanistic insights gained from recurrent
MR after RA, several techniques have been proposed as
ither adjuncts or alternatives to RA. These techniques seek
o improve leaflet coaptation by minimizing LT and cor-
ecting PPM displacement by addressing either the leaflets
ith leaflet extension
Ischemia LEX ANOVA
0.57  0.05 1.04  0.10* P  .001
1.53  0.10 1.83  0.13* P  .001
1.91  0.22 2.36  0.22* P  .006
ension; ANOVA, analysis of variance; PML, posterior mitral leaflet. *P 
ost– hoc test.
igure 3. Schematic representation of the end-systolic posterior
itral leaflet edge displacement during ischemia and after leaflet
xtension (LEX). Significant shifts are shown in gray. Data are
hown as means  standard error of the mean (*P < .05, repeated-
easures analysis of variance with the Dunnett post-hoc test vs
schemia). AML, Anterior mitral leaflet; PML, posterior mitraled w
et exteaflet.
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A
CDr the subvalvular geometry. Most proposed interventions
ave been developed in experimental animals and aim at
estoring subvalvular geometry through infarct placation18
nfarct restraint with an external mesh patch,19 or external
apillary muscle repositioning with an epicardial inflatable
alloon.20 Internal papillary muscle repositioning has a
een clinically described.21,22 In addition, the Coapsys d-
ice (Myocor Inc, Maple Grove, Minn), which has recently
een introduced to both reduce annular septal-lateral diam-
ter and relocate the PPM, is currently under investigation
n clinical trials (RESTOR-MV, TRACE).
Messas and associates23 focused on the leaflets and -
orted improved leaflet coaptation after cutting the second-
rder chordae, but such chordal cutting has been shown to
ecrease global LV systolic function and fails to consis-
ently correct IMR.24 Moreover, deterioration in LV systol
ump performance after chordal cutting, which is due to
isruption of valvular-ventricular interaction,25 would prob-
bly be poorly tolerated in patients with IMR with previous
nfarction and impaired preoperative LV systolic function.
he Alfieri edge-to-edge technique also addresses the mitral
eaflets and seeks to improve coaptation by connecting both
eaflets, creating a “double-orifice” mitral opening26; how-
ver, without concomitant annular reduction, this tech-
iques fails to reduce IMR.27 Moreover, the use of th
echnique in patients with IMR yielded discouraging mid-
erm results in a Cleveland Clinic report.28
LEX has also been reported in patients with IMR. Dobre
nd coworkers12 reported successful use of LEX in 2 -
ients with IMR, wherein an autologous pericardial patch
as used to extend the PML in conjunction with undersized
A. On the other hand, Kincaid and colleagues29 reported
uccessful patch augmentation of the AML in 25 patients
ith IMR. Despite these reports, however, LEX has seldom
een used in patients with IMR, in contrast to rheumatic
itral disease with leaflet retraction, in which patch exten-
ion of the leaflets is established.11 To enhance mechanisti
nsight, we evaluated LEX in an experimental setting of
cute IMR. We found that LEX moderately improved IMR,
ven without concomitant annular reduction, but also exac-
rbated PML edge apical tethering.
How did PML extension reduce IMR? Mitral valve closure
s a well-orchestrated interaction of all involved structures of
he mitral apparatus, including the mitral annulus, leaflets,
hordae, papillary muscles, and left ventricle. Specifically,
itral leaflet edge position in 3-D space is determined by
onnections to the annulus and papillary muscles.30 For ex-
mple, if the papillary muscle tips and the lateral annulus
epresent the centers of 3 spheres, and the leaflet and
hordal lengths represent the radii of these spheres, the
osition of the PML edge will be at a point where the 3
pheres intersect (Figure 4). If the centers (ie, annulus
apillary muscle tip) are displaced, the radii (ie, chordal length u
The Journal of Thoracicnd leaflet length) must compensate to achieve leaflet coapta-
ion. Although surgically manipulating first-order (primary)
hordal length would be delicate and technically demanding,
ncreasing PML midline length and area by means of PML
atch extension is straightforward.
In this experiment PML extension decreased IMR, de-
pite progressive annular dilatation during ongoing isch-
mia, but increased leaflet length was also associated with
ncreased apical restriction of the PML free-edge (Figure
his tethering effect can be explained by the increased
ension of all the chordae on the mitral leaflets caused by
PM dislocation during ischemia. PML patch extension in
his experiment was accomplished while preserving the
ttachments of the second-order chordae on the leaflet side
f the incision; annular-papillary continuity was therefore
reserved. By increasing the length of the PML while keep-
ng the second-order and marginal chordae on the leaflet
ide, however, this technique would tend to encourage fur-
her displacement of the leaflet edge into the ventricular
avity (Figure 1, D). Based on this mechanism, we specu
hat PML extension might further enhance leaflet coapta-
ion, with improved leaflet coaptation height when com-
ined with RA, although annular reduction was not used in
his experiment.
In the current ovine model the pericardial patch was
ewn into the PML central scallop because the anterolateral
nd posteromedial scallops are extremely small and poorly
efined in sheep. In the clinical setting, however, we would
dvocate that the patch should augment the posteromedial
Carpentier P3) scallop,12 because the IMR leak is usua
ocated more toward the posterior commissure in patients.
he size of the pericardial patch has to be tailored individ-
igure 4. Concept of intersecting spheres with respect to pre-
icted end-systolic leaflet 3-dimensional geometric configura-
ion. Leaflet edge position is determined by 3 intersecting spheres
f associated anatomic structures. The papillary muscle tips and
he mitral annulus define the centers of the spheres, whereas
hordal length and leaflet length define the radii. APM, Anterior
apillary muscle; PPM, posterior papillary muscle.ally to each patient on the basis of intraoperative assess-
and Cardiovascular Surgery ● Volume 131, Number 4 873
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A
CDent. Although we cannot speculate on the durability of this
ype of repair in the clinical IMR setting, patch extension of
itral leaflets is an established technique in rheumatic mi-
ral disease. An additional concern with the use of LEX is
V outflow tract obstruction caused by systolic anterior
ovement (SAM) of the AML, which is rare after mitral
alve repair but might occur after major downsizing of the
itral annulus. Even though annular reduction was not used
n this acute experiment, we chose to focus on PML exten-
ion for this reason. In the setting of chronic IMR, however,
he danger of SAM is probably nonexistent because of the
ncreased aortomitral angle that results from ventricular
ilation in these patients. Recent studies have documented
o SAM after restrictive annuloplasty for IMR.8
Although LEX might help increase leaflet coaptation by
ugmenting leaflet area to compensate for PML apical re-
triction (Table 2), it fails to address the underlying 
ricular pathology in IMR. Because combined coronary
evascularization and RA is required in most patients, the
dditional complexity of LEX will significantly prolong
rossclamp time, thereby limiting its clinical utility. When
e contrast this procedure with our previous concept of
apillary muscle repositioning using a transventricular su-
ure (STRING technique) from the PPM tip to the right
brous trigone,31 we would favor the STRING techniq
ecause of its simplicity, rapidity, ability to be adjusted after
eaning from bypass, and similar improvement of IMR.
ike Kron and colleagues,21 who have advocated suc
urgical relocation of the PPM, the STRING technique
llows direct manipulation of the subvalvular geometry
nder echocardiographic guidance after undersized RA to
educe LT by bringing the PPM closer to the midseptal
nnulus (ie, the anterior mitral annular saddle horn). The
ransventricular suture then sets the tethering length be-
ween the midseptal annulus and PPM tip to help prevent
ecurrent PPM dislocation caused by progressive postinfarc-
ion LV dilatation.
Several important study limitations should be mentioned.
hese data were obtained in an acute, open-chest setting in
ormal sheep hearts immediately after an open cardiac
urgical procedure, and therefore direct extrapolation of
hese findings to human subjects must be done with caution.
he investigation of acute IMR in open-chest sheep is
ifferent from the clinical scenario of chronic IMR. Al-
hough we studied the efficacy of LEX in the setting of
cute IMR, the mechanisms described are probably similar
n the chronic IMR context. Septal-lateral mitral annular
ilation is important in both acute32 and chronic33 IMR, and
imilar alterations in subvalvular geometry characterized by
osterior, lateral, and basal displacement of the PPM caus-
ng posterior leaflet apical displacement occur during acute
schemia,32 although not as pronounced as after chro
osterior infarction.33 These similarities support the use of
74 The Journal of Thoracic and Cardiovascular Surgery ● Apri-
n acute ischemia model to test the efficacy of LEX. Con-
istent with these previous studies of acute and chronic
MR, increased end-systolic mitral annular septal-lateral
iameter and area were observed during ischemia. How-
ver, because of the experimental design, wherein data were
cquired at baseline and then during proximal circumflex
schemia and during ongoing ischemia after release of the
atch-reefing suture, it is not possible to discern whether the
rogressive annular dilatation observed between ischemia
nd LEX conditions was due to ongoing ischemia or pos-
ibly augmented by unfurling of the reefing stitch (which
ight have been serving as a regional annular plication).
imilarly, the worsening of dP/dt and end-systolic and end-
iastolic pressures and volumes after LEX might reflect this
xperimental design (Table 1), wherein data after LEX 
cquired during prolonged ischemia (after acquisition of the
schemia data) in all animals. Nevertheless, LEX was asso-
iated with decreased MR in all animals, even without
oncomitant annular reduction, despite ongoing ischemia.
ifferences in comparative anatomy between human and
heep mitral valve and subvalvular anatomy might also be
mportant. Sheep might have a relatively small leaflet/
nnular area ratio, which makes them more susceptible to
maller increases in annular area compared with human
ubjects. Ultimately, future studies in a chronic IMR model
re required to assess the efficacy of this patch repair
echnique in conjunction with RA.
We appreciate the superb technical assistance provided by
aggie Brophy, AS; Katha Gazda, BA; and Mark Grisedale,
VM.
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iscussion
r Robert C. Gorman (Philadelphia, Pa). Frank, I want to
ongratulate you on an excellent presentation and interesting ex-
eriment. The intellectual and physical fortitude required to per-
orm these kinds of experiments is substantial.
IMR is a humbling problem for surgeons, one where we fail our
atients on several levels. First of all, as you have alluded to, we
re not nearly as good as we think we are at eliminating IMR.
tudies like the ones you have presented and others performed by
our group in the past are valuable, if for no other reason than that
hey draw attention to the inadequacies of our established tech-
iques and therefore stimulate interest in developing new ap-
roaches.
Because of our own experimental studies, as well as a critical
nd in-depth review of all the existing literature, we have become
ery pessimistic about the value of any surgical approach to
hronic IMR. Even for patients in whom a durable repair is
chieved or the valve is replaced, the heart often remains dilated,
nd longevity is very rarely improved. These sobering facts have
ed us to think of IMR not as a primary pathology but really as a
anifestation of end-stage and irreversible infarction-induced ven-
ricular remodeling.
We believe that the true challenge for surgeons and cardiolo-
ists in the 21st century is the development of strategies designed
o be implemented early after infarction that are intended to
revent rather than to reverse infarction-induced remodeling.
I have 2 questions regarding the data you have presented today.
First, does the inherent instability of the animal preparation that
ou have used, the difficulty in doing quantitative transesophageal
chocardiography in sheep, the nontrivial baseline MR, and the
esidual MR after LEX affect the confidence you have in your
onclusions?
Second, and more importantly, your group and others have
haracterized the mechanism of acute and chronic IMR in the
heep model. The mechanism for these manifestations of ventric-
lar remodeling is really quite different. Because chronic IMR is
he critical problem faced by surgeons, why did you choose to
tudy the acute IMR model? What implications do your findings
ave for the treatment of chronic IMR?
Dr Langer. The acute IMR in this model was induced by
roximal circumflex occlusion. Of course we lost some of the
and Cardiovascular Surgery ● Volume 131, Number 4 875
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CDnimals because of malignant arrhythmias. The ischemia data run
as usually started between 45 and 70 seconds after the onset of
schemia. We started the run as soon as moderate MR was ob-
erved on transesophageal echocardiography; most of the animals
ad moderate or severe MR. I have to admit that patch retraction
ight have induced some structural MR (baseline MR grade of
.9), but this went up to 2.4 during ischemia. The acute IMR was
educed by about 1 grade with LEX. We did not eliminate the IMR
ompletely, but we speculate that LEX in conjunction with RA
ight help in selected patients.
Referring to your second question, you are correct. We initially
valuated this technique in the acute setting as a pilot experiment.
his is our standard approach in exploring new repair concepts to
eep costs and animal attrition down. The mechanisms responsible
or the IMR in the acute and the chronic context are surprisingly
ot all that dissimilar; it is primarily just a difference in the
agnitude of the pathologic geometric changes that differentiates
he 2 conditions. On the other hand, I agree that a chronic exper-
mental IMR animal model better mimics the clinical setting of
atients with chronic IMR caused by ischemic heart disease.
Dr Masashi Komeda (Kyoto, Japan). Congratulations on an-
ther success of the new way of treatment for IMR.
I have one question. I always follow Dr Miller’s suggestion that
ventricular solution is necessary for ventricular disease, and this
s obviously ventricular disease. From that viewpoint, this new
ethod, although very elegant, for me looks a little bit like a
alvular solution for ventricular disease. Of course, realistically it
ight be necessary, but I want to hear your opinion about that. In
ther words, by doing LEX, it might possibly allow the posterior
all further dilatation.
Dr Langer. Excellent question, Dr Komeda. After I moved
ack to Homburg, Germany, after my research in the Miller lab at
tanford, we attempted to translate these experimental approaches
nto clinical practice. Based on this experience, we do think that in
subset of patients, a ring is not going to be enough, and therefore
e have to do something more. In fact, we did favor repositioning
f the posterior papillary muscle, not only because of the simplic-
ty of this approach but also because of what you just pointed out,
hat we do think that this subvalvular technique is a better ap-
roach to a ventricular disease.
Dr Robert W. M. Frater (Bronx, NY). We all agree that we
eed better ventricular anterior leaflet response. But if you are
oing to extend the posterior leaflet to mobilize it—we know
hat it is immobilized in these circumstances—should you not
nclude also the P3 area, as well as the P2 area, because a good
eal of the insufficiency comes from between the scallops in
his form of mitral insufficiency? And you have extended only
he central area. You really need to extend the area between the
ommissure and the central leaflet as well, I believe. I ask your
pinion on that.
Dr Langer. I totally agree with that, Dr Frater. Dr Miller
sually says, “The leak is in the southeast corner.” When we
esigned this experiment, we were stimulated by a case report
y Dobre and coworkers from Sweden, who performed LEX in
onjunction with an RA in 2 patients with IMR. And indeed,
hey placed the pericardial patch starting from the leaflet center
xtending into the P3 segment. In clinical practice I think this
s the way to go. Sheep, however, have a sizeable middle d
76 The Journal of Thoracic and Cardiovascular Surgery ● Apricallop along with 2 anterolateral and posteromedial subscal-
ops that are rudimentary and almost nonexistent. With my
imited surgical skills, I was happy that I was able to put a patch
n the middle scallop; I think it is nearly technically impossible
o place a patch in the posteromedial scallop of an ovine
osterior leaflet.
Dr Radu C. Deac (Targu-Mures, Romania). I enjoyed very
uch the presentation.
We used this technique back in 1982 in 33 clinical rheumatic
ases. During the following years, the patch inserted in the poste-
ior leaflet was covered with the patient’s own tissue and became
ess pliable. The majority of valves were replaced in time because
f loss of function.
There are 2 issues to be raised here. One is the technique, and
he other is the type of tissue used for reconstruction.
Considering the technique, the patch should be as far as pos-
ible from the posterior insertion of the valve because if it is too
lose, it will cover all the wrong tissue very easily.
Second, incision in the posterior leaflet allows access to val-
ular structure not seen otherwise. And from the tissue point of
iew, it is important to be autologous and very thin. Professor
arpentier’ group also published a group with this technique with
utologous pericardium.
My question is this: Do you plan to do a chronic study with this
echnique?
Dr Langer. Our group has been looking forward to the dis-
ussion this morning. We had heard earlier from some who had
ead our abstract that “We have done this before, but it didn’t
ork . . . .”
We wanted to take the opportunity of this discussion to find out
hy it did not work well in the clinical world. In our model of
cute MR, it did result in moderate improvement in IMR. We are
urious what the audience experienced in their patients with IMR
nd why LEX did not work in the long term.
We have not planned a chronic experiment yet. We wanted to
enerate paired data by unfurling of the leaflet in the same animal,
hich is probably not possible in a chronic experiment. We
voided the use of glutaraldehyde fixation or bovine pericardium
ecause we were worried that the patch would not unfurl ade-
uately. In a chronic experiment you would have to compare 2
ifferent groups of animals (control vs LEX).
Dr Alain F. Carpentier (Paris, France). I rise to congratulate
ou for bringing to our attention what is still a challenging prob-
em, that is to say, the management of ischemic mitral valve
egurgitation.
I have been using LEX for 2 decades in restricted leaflet
otion, mainly in rheumatic valvular disease, and I can confirm
hat provided that you use a glutaraldehyde-treated autologous
ericardium, it does not shrink. Therefore this technique is appeal-
ng and works long term, both in rheumatic valve disease and
ongenital malformation.
Now IMR is another story. It is another story because it is a
yocardial disease rather than a valvular disease. It is true that you
an correct mitral valve regurgitation with LEX in IMR, but it is
oing to be temporary. That is the first drawback.
The second drawback is that you have to enlarge the P2-P3
egment. And in this area, particularly in ischemic mitral valve
isease, the leaflet tissue is very fragile, very thin, and therefore
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have done it several times, but I have abandoned using it, and I
refer to reinforce the myocardium with some sort of support so as
o treat the cause of recurrent regurgitation.
Dr Langer. First of all, I have to say I feel very honored to talk
bout the mitral valve in the presence of Professor Carpentier. Of
ourse I agree with what you said.
Kincaid and associates reported successful patch augmentation
f the AML in a case series of 25 patients with IMR (Annals of
horacic Surgery, 2004). We have avoided this approach because
e do think there might be a chance of creating SAM. Do you have
ny personal experience with patch extension of the anterior leaflet
or patients with IMR?
Dr Carpentier. You mean the risk of SAM?
Dr Langer. The anterior leaflet, did you extend the anterioreaflet also, or just the posterior leaflet like we did?
The Journal of ThoracicDr Carpentier. I am not sure I understand properly your
uestion.
Dr Langer. There was a group who reported augmentation of
he anterior leaflet. Have you ever done that?
Dr Carpentier. Yes, I mean—
Dr Langer. For ischemics.
Dr Carpentier. You mean enlargement of the anterior leaf-
et?
Dr Langer. Correct. There was a case report published in the
nnals—
Dr Carpentier No, it does not make sense because the tether-
ng is located at P2-P3, mainly P3 and the commissural area. If you
ant to be successful in IMR, this is the area you have to enlarge,
nd not the anterior leaflet.
Dr Langer. Thank you.
and Cardiovascular Surgery ● Volume 131, Number 4 877
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